A new interdisciplinary study from BYU, opens an angle of neuroimmune research that could potentially lead to better medical ...

Ozempic and similar semaglutide-based medications have been hailed as miracle drugs. Known as GLP-1 (glucagon-like peptide-1) agonists, this class of medications mimics a natural hormone the small ...

Addiction, a chronic mental health condition, affects millions of Americans, and traditional treatments have often fallen short of providing lasting relief. However, a new class of medications, GLP-1 ...

GLP-1 agonist medications such as Ozempic have been game changers in the treatment of obesity and diabetes. Recently, a new study found evidence that Ozempic may be a promising medicine for ...

You're reading Part 1 of The War on Recovery, a yearlong investigation into how the U.S. denies lifesaving medications to people with opioid addiction. These medicines are cheap and easy to distribute ...

A new study has identified the top reasons why some physicians may be reluctant to intervene in addiction. The comprehensive review, pulling 283 studies published on this topic within the last 61 ...

Addiction medicine is currently recognized as a medical specialty. However, many people, including other medical specialists, think of addiction medicine as a "fringe" specialty, treating addiction ...

People who work in addiction medicine in the 1930s and 2020s still argue community support is the biggest need in recovery. The Federal Medical Center in Lexington has a fairly simple purpose — it’s a ...

Indiana's recent tobacco tax increase creates an opportunity to address the combined challenge of tobacco and opioid addiction. People with substance use disorders, including those in treatment for ...

This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Danny Lewis: For most of his life, Joe Hilton has struggled with addiction and ...